
Camallergy
Coming March 2, 2023
Camallergy has developed an oral immunotherapy that provides protection for the more than 6 million people with peanut allergies.
Camallergy has developed an oral immunotherapy that provides protection for the more than 6 million people with peanut allergies.
InSitu Biologics has developed a new technology that provides 5 days of pain management without using OPIOIDS!
Innovative, sustained release technology provides relief from back pain for 60 to 90 days without opioids.
BloombergNEF projects more than 1 million battery-electric light and medium-duty commercial vehicles will be on the road in the U.S. by 2030.
Boom Supersonic is revolutionizing commercial flight by bringing supersonic flight back to the skies with Overture.
Kendra Barkoff Lamy, former Press Secretary to Vice President Joe Biden, and Dr. Tom Pey, CEO of Waymap discuss making cities more accessible
AOBiome Therapeutics has developed a topical biologic spray that is effective in a broad array of inflammatory skin conditions
TumorMAP from CytoVeris enables general surgeons to operate with the precision of the most experienced TURBT specialist.
Camallergy has developed an innovative treatment for the more than 6 million people in the U.S. and Europe who live with peanut allergies.
Join our webinar to hear from Ms. Pilon and ReAlta CEO, Dr. Ulrich Thienel as they discuss how this treatment can save lives and prevent lifelong disabilities in newborn infants.
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |